Director, Cancer Translational Immunotherapy Center Cancer & Blood Diseases Institute
Location: Cincinnati, Ohio
Type: Full Time
Preferred Education: Doctorate
Academic Medical Group
Cincinnati Children's offer a competitive wage and compensation package based on training and experience. Includes defined contribution retirement plan, paid time off/ paid holidays, CME days off and allowance, and relocation assistance for external hires
Internal Number: 117411
The Cancer & Blood Diseases Institute at Cincinnati Children’s Hospital is seeking an innovative and dynamic Director for its Cancer Translational Immunotherapy Center. The objective for the position is to lead - and expand through recruitment - a team of investigators focused on developing engineered cellular and vaccine immunotherapies for pediatric and young adult cancers. The research program integrates into a large and well-established program for clinical stem cell transplant and cellular therapies, with over 7 years of clinical CART experience, and internationally-noted program for viral-specific T-cell therapies, and over 100 transplants per year. Cincinnati Children’s is also home to one of the nation’s leading GMP viral vector and cell processing facilities. The cancer programs at Cincinnati Children’s are a global center for referral of high risk and relapsed cancers, with a strong bench-to-bedside team science culture and portfolio of investigator-initiated and first in patient clinical trials.
Cincinnati Children’s has a robust research environment and is ranked in the top 3 of all national pediatric departments in receipt of NIH funding. The Department of Pediatrics counts 753 faculty across 42 divisions. The Cancer and Blood Diseases Institute incorporates and integrates four divisions (Hematology, Oncology, Experimental Hematology & Cancer Biology, and Bone Marrow Transplantation and Immune Deficiency), with a total of 946 members, including 86 faculty members The Cancer and Blood Diseases is recognized as a global center for care, research and training; approximately 65% of patients are referred to it from outside of metropolitan Cincinnati for advanced and technically-demanding therapies. The Division of Infectious Diseases is recognized as an international leading center for vaccine research and development. US News and World Report recognized Cincinnati Children’s as the #3 ranked institution for pediatric cancer care in the United States in 2020, and ranked CBDI #1 in 2013 and 2018.
Key elements for the successful candidate include:
M.D. or equivalent, and/or Ph.D. with focused experience in engineered cellular or vaccine immunotherapy development with strong publication and funding accomplishments
Research focus on pediatric and/or young adult malignancies
Substantial expertise in the molecular engineering of cellular therapies or novel vaccines for cancer, with evidence of ability to develop new technologies and applications
Evidence of strong multidisciplinary team leadership and communication skills, and ability to collaborate effectively with other laboratory research and clinical leaders and their teams.
Aptitude and proficiency for strategic planning and execution
Commitment to diversity, equity, and inclusion in research, education, and clinical care delivery.
Care dives us, science moves us, discovery inspires us. We are touched by humanity, and propelled by compassion. This isn't our job it's our calling and we answer it every day for every family and every child and every future.
We are Cincinnati Children's come join us to change the outcome together
Cincinnati Children's is an Equal Opportunity Employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age genetic information, physical or mental disability, military or veteran status, sexual orientation, or other protected status in accordance with applicable federal, state and local laws and regulations.